NCT04009733View on ClinicalTrials.gov

Epigenetic Regulation of Osteogenesis Imperfecta Severity : miROI Study

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 3, 2019

Primary Completion Date

April 24, 2022

Study Completion Date

April 24, 2022

Conditions
Osteogenesis Imperfecta
Interventions
BIOLOGICAL

Blood sample

A study specific blood sample will be collected.

BIOLOGICAL

Blood sample

Pre-collected serum of cohort OFELY and MODAM for women, STRAMBO for men will be used for the study.

Trial Locations (1)

69003

Hôpital Edouard Herriot, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04009733 - Epigenetic Regulation of Osteogenesis Imperfecta Severity : miROI Study | Biotech Hunter | Biotech Hunter